Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Rockx, Barry, Kuiken, Thijs, Herfst, Sander, Bestebroer, Theo, Lamers, Mart M., Oude Munnink, Bas B., de Meulder, Dennis, van Amerongen, Geert +16 more·2020·Science
DOI 10.1126/science.abb7314

Cited by (878)

Items 101–200 of 878

  1. Mink, SARS-CoV-2, and the Human-Animal Interface
    Florence Fenollar, Oleg Mediannikov, Max Maurin, Christian Albert Devaux, Philippe Colson, Anthony Levasseur, Pierre‐Edouard Fournier, Didier Raoult · 2021 · Frontiers in Microbiology
  2. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
    Francisco Javier Salguero, Andrew White, Gillian S. Slack, Susan A. Fotheringham, Kevin R. Bewley, Karen E. Gooch, Stéphanie Longet, Holly E. Humphries, Robert J. Watson, Laura E. Hunter et al. · 2021 · Nature Communications
  3. Clinical and Pathological Findings in SARS-CoV-2 Disease Outbreaks in Farmed Mink ( Neovison vison )
    Robert Jan Molenaar, Sandra Vreman, Renate W. Hakze‐van der Honing, Rob Zwart, Jan de Rond, Eefke Weesendorp, Lidwien A.M. Smit, Marion Koopmans, Ruth Bouwstra, Arjan Stegeman et al. · 2020 · Veterinary Pathology
  4. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
    Jean‐Sélim Driouich, Maxime Cochin, Guillaume Lingas, Grégory Moureau, Franck Touret, Paul-Rémi Petit, Géraldine Piorkowski, Karine Barthélémy, Caroline Laprie, Bruno Coutard et al. · 2021 · Nature Communications
  5. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site
    Anna Z. Mykytyn, Tim I. Breugem, Samra Riesebosch, Debby Schipper, Petra B. van den Doel, Robbert J. Rottier, Mart Matthias Lamers, Bart L. Haagmans · 2021 · eLife
  6. Single-cell transcriptomic atlas of primate cardiopulmonary aging
    Shuai Ma, Shuhui Sun, Jiaming Li, Yanling Fan, Jing Tao Qu, Liang Sun, Si Wang, Yiyuan Zhang, Shanshan Yang, Zunpeng Liu et al. · 2020 · Cell Research
  7. An Overview of SARS-CoV-2 and Animal Infection
    Mohamed A. A. Mahdy, Waleed Younis, Zamzam M. Ewaida · 2020 · Frontiers in Veterinary Science
  8. Bibliometric Analysis on COVID-19: A Comparison of Research Between English and Chinese Studies
    Jingchun Fan, Ya Gao, Na Zhao, Runjing Dai, Hailiang Zhang, Xiaoyan Feng, Guoxiu Shi, Jinhui Tian, Che Chen, Brett David Hambly et al. · 2020 · Frontiers in Public Health
  9. SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents
    Anna C. Fagre, Juliette Lewis, Miles Eckley, Shijun Zhan, Savannah M. Rocha, Nicole R. Sexton, Bradly E. Burke, Brian J. Geiss, Olve B. Peersen, Todd A. Bass et al. · 2021 · PLoS Pathogens
  10. Role of Hypertension on the Severity of COVID-19: A Review
    Mei Peng, Jia He, Ying Xue, Yang Xue, Shao Liu, Zhicheng Gong · 2021 · Journal of Cardiovascular Pharmacology
  11. SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts
    Amy L. Hartman, Sham Nambulli, Cynthia M. McMillen, Alexander G. White, Natasha L. Tilston‐Lunel, Joseph R. Albe, Emily L. Cottle, Matthew Dunn, Lonnie James Frye, Theron H. Gilliland et al. · 2020 · PLoS Pathogens
  12. Endothelial cells are not productively infected by SARS‐CoV‐2
    Lilian Schimmel, Keng Yih Chew, Claudia J. Stocks, Teodor E. Yordanov, Patricia Essebier, Arutha Kulasinghe, James H. Monkman, Anna Flavia Ribeiro dos Santos Miggiolaro, Caroline Louise Cooper, Lúcia de Noronha et al. · 2021 · Clinical & Translational Immunology
  13. Susceptibility of rabbits to SARS-CoV-2
    Anna Z. Mykytyn, Mart Matthias Lamers, Nisreen M.A. Okba, Tim I. Breugem, Debby Schipper, Petra B. van den Doel, Peter van Run, Geert van Amerongen, Leon de Waal, Marion Koopmans et al. · 2020 · Emerging Microbes & Infections
  14. Acute Respiratory Distress in Aged, SARS-CoV-2–Infected African Green Monkeys but Not Rhesus Macaques
    Robert V. Blair, Monica Vaccari, Lara A. Doyle‐Meyers, Chad J. Roy, Kasi Russell‐Lodrigue, Marissa D. Fahlberg, Chris J. Monjure, Brandon J. Beddingfield, Kenneth S. Plante, Jessica A. Plante et al. · 2020 · American Journal Of Pathology
  15. Neurological complications and infection mechanism of SARS-CoV-2
    Dandan Wan, Tingfu Du, Weiqi Hong, Li Chen, Haiying Que, Shuaiyao Lu, Xiaozhong Peng · 2021 · Signal Transduction and Targeted Therapy
  16. A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
    Yang, Ren, Deng, Yao, Huang, Baoying, Huang, Lei, Lin, Ang, Li, Yuhua, Wang, Wenling, Liu, Jingjing, Lu, Shuaiyao, Zhan, Zhenzhen et al. · 2021 · Signal Transduction and Targeted Therapy
  17. A humanized mouse model of chronic COVID-19
    Esen Sefik, Benjamin Israelow, Haris Mirza, Jun Zhao, Rihao Qu, Eleanna Kaffe, Eric Song, Stephanie Halene, Eric Meffre, Yuval Kluger et al. · 2021 · Nature Biotechnology
  18. Assessing the risks of SARS-CoV-2 in wildlife
    Richard John Delahay, José de la Fuente, G. C. Smith, Khan Sharun, Emma Snary, Luis Flores Giron, Julius Nziza, Anthony R. Fooks, Sharon M. Brookes, Fabian Z. X. Lean et al. · 2021 · One Health Outlook
  19. Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins
    Yajuan Rui, Jiaming Su, Si Shen, Ying Hu, Dingbo Huang, Wenwen Zheng, Meng Lou, Yifei Shi, Meng Wang, Shiqi Chen et al. · 2021 · Signal Transduction and Targeted Therapy
  20. The Gastrointestinal Tract Is an Alternative Route for SARS-CoV-2 Infection in a Nonhuman Primate Model
    Jiao Li, Haiyan Li, Jingwen Xu, Mengli Yang, Chunxia Ma, Jingmei Li, Siwen Zhao, Haixuan Wang, Yun Yang, Wenhai Yu et al. · 2020 · Gastroenterology
  21. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models
    Rafał Butowt, Nicolas Meunier, Bertrand Bryche, Christopher S. von Bartheld · 2021 · Acta Neuropathologica
  22. Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
    Lambert, Paul-Henri, Ambrosino, Donna M., Andersen, Svein R., Baric, Ralph S., Black, Steven B., Chen, Robert T., Dekker, Cornelia L., Didierlaurent, Arnaud M., Graham, Barney S., Martin, Samantha D. et al. · 2020 · Vaccine
  23. SARS-CoV-2 Invades the Central Nervous System via the Olfactory Route in Rhesus Monkeys
    Jiao Li, Yun Yang, Wenhai Yu, Yuan Zhao, Haiting Long, Jiahong Gao, Kaiyun Ding, Chunxia Ma, Jingmei Li, Siwen Zhao et al. · 2020 · Signal Transduction and Targeted Therapy
  24. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice
    Huang, Kun, Zhang, Yufei, Hui, Xianfeng, Zhao, Ya, Gong, Wenxiao, Wang, Ting, Zhang, Shaoran, Yang, Yong, Deng, Fei, Zhang, Qiang et al. · 2021 · EBioMedicine
  25. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection
    Zhuo Long Zhou, Xinyi Zhang, Xiaobo Lei, Xia Xiao, Tao Jiao, Ruiyi Ma, Xiaojing Dong, Qi Jiang, Wenjing Wang, Yujin Shi et al. · 2021 · Signal Transduction and Targeted Therapy
  26. Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation
    Jérôme Cattin‐Ortolá, Lawrence G. Welch, Sarah Maslen, Mark J. Skehel, Guido Papa, Leo C. James, Sean Munro · 2021 · Nature Communications
  27. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
    Shen Wang, Wujian Li, Zhenshan Wang, Wanying Yang, Entao Li, Xianzhu Xia, Feihu Yan, Sandra Chiu · 2024 · Signal Transduction and Targeted Therapy
  28. Potential zoonotic sources of SARS‐CoV‐2 infections
    Wendy Karen Jo, Edmilson Ferreira de Oliveira-Filho, Andrea Rasche, Alex David Greenwood, Nikolaus Osterrieder, Jan Felix Drexler · 2020 · Transboundary and Emerging Diseases
  29. Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
    Shuyu Shou, Menghui Liu, Yang Yang, Ning Kang, Yingying Song, Dan Tan, Nan-Nan Liu, Feifei Wang, Jing Liu, You-Hua Xie · 2021 · Frontiers in Microbiology
  30. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
    Khoury, David S., Wheatley, Adam K., Ramuta, Mitchell D., Reynaldi, Arnold, Cromer, Deborah, Subbarao, Kanta, O’Connor, David H., Kent, Stephen J., Davenport, Miles P. · 2020 · Nature Reviews Immunology
  31. Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity
    Thomas Perkmann, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, Robab Breyer‐Kohansal, Otto Chris Burghuber, Sylvia Hartl, Daniel Aletaha, Daniela Sieghart, Peter Quehenberger, Rodrig Marculescu et al. · 2020 · Clinical Chemistry
  32. SARS-CoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic
    Khan Sharun, Ruchi Tiwari, Senthilkumar Natesan, Kuldeep Dhama · 2020 · Veterinary Quarterly
  33. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
    Clarisse Salgado‐Benvindo, Melissa Thaler, Ali Taş, Natacha S. Ogando, Peter J. Bredenbeek, Dennis K. Ninaber, Ying Wang, Pieter Sicco Hiemstra, Eric J. Snijder, Martijn J. van Hemert · 2020 · Antimicrobial Agents and Chemotherapy
  34. Recent advances in carbon quantum dots for virus detection, as well as inhibition and treatment of viral infection
    Yuxiang Xue, Chenchen Liu, Gavin Andrews, Jinyan Wang, Yi Ge · 2022 · Nano Convergence
  35. The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
    Ahmed M. Alluwaimi, Ibrahim H. Alshubaith, Ahmed M. Al-Ali, Salah Abohelaika · 2020 · Frontiers in Veterinary Science
  36. Interactions of particulate matter and pulmonary surfactant: Implications for human health
    Feifei Wang, Jifang Liu, Hongbo Zeng · 2020 · Advances in Colloid and Interface Science
  37. The unique features of SARS‐CoV‐2 transmission: Comparison with SARS‐CoV, MERS‐CoV and 2009 H1N1 pandemic influenza virus
    Zhonglan Wu, David Harrich, Zhongyang Li, Dongsheng Hu, Dongsheng Li · 2020 · Reviews in Medical Virology
  38. Hunting coronavirus by transmission electron microscopy – a guide to SARS‐CoV‐2‐associated ultrastructural pathology in COVID‐19 tissues
    Helmut Hopfer, Martin C. Herzig, Rainer Gosert, Thomas Menter, Jürgen Hench, Alexandar Tzankov, Hans Hellmuth Hirsch, Sara Miller · 2020 · Histopathology
  39. Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
    Qian‐Fang Meng, Wanbo Tai, Mingyao Tian, Xinyu Zhuang, Yuanwei Pan, Jialin Lai, Yangtao Xu, Zhiqiang Xu, Min Li, Guangyu Zhao et al. · 2023 · Science Advances
  40. Risk of human‐to‐wildlife transmission of SARS‐CoV‐2
    Sophie Gryseels, Luc De Bruyn, Ralf Gyselings, Sébastien Calvignac‐Spencer, Fabian Hubertus Leendertz, Herwig Leirs · 2020 · Mammal Review
  41. SARS-CoV-2 spike protein–induced cell fusion activates the cGAS-STING pathway and the interferon response
    Xiaoman Liu, Wei Ping Liang, Fengwen Xu, Fei Zhao, Yu Huang, Zhangling Fan, Shan Mei, Yamei Hu, Linxuan Zhai, Justin Guo et al. · 2022 · Science Signaling
  42. Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?
    Gary Wong, Yuhai Bi, Qi-Hui Wang, Xin-Wen Chen, Zhigang Zhang, Yong‐Gang Yao · 2020 · 动物学研究
  43. Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans
    Linda J. Saif, Kwonil Jung · 2020 · Journal of Clinical Microbiology
  44. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
    Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, Takumi Koshiba, Grégoire Paul Millet · 2020 · iScience
  45. Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models
    Gan Wang, Meng-Li Yang, Zi-Lei Duan, Feng-Liang Liu, Lin Jin, Cheng-Bo Long, Min Zhang, Xiao-Peng Tang, Ling Xu, Ying-chang Li et al. · 2020 · Cell Research
  46. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection
    R. Pei, Jian-Qi Feng, Yecheng Zhang, Hao Sun, Lian Li, Xuejie Yang, Jiang-Ping He, Shuqi Xiao, Jin Xiong, Ying Lin et al. · 2020 · Protein & Cell
  47. In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
    Sakshi Piplani, Puneet Kumar Singh, David Alan Winkler, Nikolai Petrovsky · 2021 · Scientific Reports
  48. A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
    Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Martje Fentener van Vlissingen, Thijs Kuiken, Wenyu Han, Corine H. GeurtsvanKessel, Yuhuan Gong et al. · 2021 · Nature Communications
  49. Animal models for COVID-19: advances, gaps and perspectives
    Changfa Fan, Yong Wu, Rui Xiong, Yuansong Yang, Chen Ling, Susu Liu, Shunan Liu, Youchun Wang · 2022 · Signal Transduction and Targeted Therapy
  50. Approaches and Challenges in SARS-CoV-2 Vaccine Development
    Dagotto, Gabriel, Yu, Jingyou, Barouch, Dan H. · 2020 · Cell Host & Microbe
  51. Susceptibility of tree shrew to SARS-CoV-2 infection
    Yuan Zhao, Junbin Wang, Dexuan Kuang, Jingwen Xu, Mengli Yang, Chunxia Ma, Siwen Zhao, Jingmei Li, Haiting Long, Kaiyun Ding et al. · 2020 · Scientific Reports
  52. Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
    Gregory D. Sempowski, Kevin O. Saunders, Priyamvada Acharya, Kevin J. Wiehe, Barton F. Haynes · 2020 · Cell
  53. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota
    Harry Sokol, Vanessa Contreras, Pauline Maisonnasse, Aurore Desmons, Benoît Delache, Valentin Sencio, Arnaud Machelart, Angela Brisebarre, Lydie Humbert, Lucie Deryuter et al. · 2021 · Gut Microbes
  54. Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation
    Mart Matthias Lamers, Anna Z. Mykytyn, Tim I. Breugem, Yiquan Wang, Douglas C. Wu, Samra Riesebosch, Petra B. van den Doel, Debby Schipper, Theo M. Bestebroer, Nicholas C. Wu et al. · 2021 · eLife
  55. Brain Inflammation and Intracellular α-Synuclein Aggregates in Macaques after SARS-CoV-2 Infection
    Ingrid H.C.H.M. Philippens, Kinga P. Böszörményi, Jacqueline A. M. Wubben, Zahra C. Fagrouch, Nikki van Driel, Amber Q. Mayenburg, Diana Lozovagia, Eva Roos, Bernadette Schurink, Marianna Bugiani et al. · 2022 · Viruses
  56. Nanocarrier vaccines for SARS-CoV-2
    Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, M. M. Abdelmoaty, Jacob D. Cohen, P. Singh, Ashish Baldi, N. Bajwa, Raj Kumar et al. · 2021 · Advanced Drug Delivery Reviews
  57. SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study
    T. Prince, Shirley L. Smith, A. Radford, T. Solomon, G. Hughes, E. I. Patterson · 2021 · Viruses
  58. Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
    Per Johan Klasse, Douglas F. Nixon, John P. Moore · 2021 · Science Advances
  59. Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck
    Katarina M. Braun, Gage K. Moreno, Peter Halfmann, Emma B. Hodcroft, David A. Baker, Emma C. Boehm, Andrea M. Weiler, Amelia K. Haj, Masato Hatta, Shiho Chiba et al. · 2021 · PLoS Pathogens
  60. The search for a COVID-19 animal model
    Seema S. Lakdawala, Vineet D. Menachery · 2020 · Science
  61. Thoughts on the alveolar phase of COVID-19
    Robert J. Mason · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  62. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses
    Debanjan Banerjee, Biju Viswanath · 2020 · Asian Journal of Psychiatry
  63. Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases
    Miroslav Sekulic, Holly Lynn Harper, Behtash Ghazi Nezami, Daniel Shen, Simona Pichler Sekulic, Aaron T Koeth, Clifford V. Harding, Hannah L. Gilmore, Navid Sadri · 2020 · American Journal of Clinical Pathology
  64. Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
    Lei Shuai, G. Zhong, Q. Yuan, Zhiyuan Wen, Chong Wang, Xi-Jun He, Renqiang Liu, Jin-Liang Wang, Qin-Jian Zhao, Yu-Xiu Liu et al. · 2020 · National Science Review
  65. COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
    Ramandeep Singh, Alisha Kang, Xiang‐Qian Luo, Mangalakumari Jeyanathan, Amy E. Gillgrass, Sam Afkhami, Zhou Xing · 2021 · The FASEB Journal
  66. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection
    Komudi Singh, Yunching Chen, Shahin Hassanzadeh, Kim Han, Jennifer Judy, Fayaz Seifuddin, Ilker Tunc, Michael N. Sack, Mehdi Pirooznia · 2021 · Frontiers in Genetics
  67. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
    Mariano Carossino, Devin Kenney, Aoife Kateri O’Connell, Paige Montanaro, Anna E. Tseng, Hans P. Gertje, Kyle A. Grosz, Maria Ericsson, Bertrand R. Huber, Susanna A. Kurnick et al. · 2022 · Viruses
  68. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19
    Jang Hyun Park, Heung Kyu Lee · 2020 · Frontiers in Immunology
  69. A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes
    Yu Guo, Lisu Huang, Guangshun Zhang, Yanfeng Yao, He Zhou, Shū Shěn, Bingqing Shen, Bo Li, Xin Li, Qian Zhang et al. · 2021 · Nature Communications
  70. Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
    Abdolreza Esmaeilzadeh, Reza Elahi · 2020 · Journal of Cellular Physiology
  71. Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression
    Huiwen Zheng, Heng Li, Lei Guo, Yan Liang, Jing Li, Xi Wang, Yunguang Hu, Lichun Wang, Yun Liao, Fengmei Yang et al. · 2020 · PLoS Pathogens
  72. Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens
    Jun Liu, April M. Babka, Brian J. Kearney, Sheli R. Radoshitzky, Jens H. Kuhn, Xiankun Zeng · 2020 · JCI Insight
  73. COVID-19: the case for aerosol transmission
    Raymond Tellier · 2022 · Interface Focus
  74. The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection
    Jakob Trimpert, Daria Vladimirova, Kristina Dietert, Azza Abdelgawad, Dušan Kunec, Simon Dökel, Anne Voß, Achim Dieter Gruber, Luca D. Bertzbach, Nikolaus Osterrieder · 2020 · Cell Reports
  75. The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
    Damien A. Leach, Andrea Mohr, Efstathios S. Giotis, Emine Cil, A. M. Isac, Laura L. Yates, William Barclay, Ralf Michael Zwacka, Charlotte Lynne Bevan, Greg Nicholas Brooke · 2021 · Nature Communications
  76. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury
    Sarzani, Riccardo, Giulietti, Federico, Di Pentima, Chiara, Giordano, Piero, Spannella, Francesco · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  77. COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
    John P. Moore, Per Johan Klasse · 2020 · Journal of Virology
  78. Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence-
    Cosmo Godino, Andrea Scotti, Norma Maugeri, Nicasio Mancini, Evgeny V. Fominskiy, Alberto Margonato, Giovanni Landoni · 2020 · International Journal of Cardiology
  79. Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2
    Ilya R. Fischhoff, Adrian A. Castellanos, João Rodrigues, Arvind Varsani, Barbara A. Han · 2021 · Proceedings of the Royal Society B Biological Sciences
  80. A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant
    Man Chun Chiu, Cun Li, Xiaojuan Liu, Yifei Yu, Jingjing Huang, Zhixin Wan, Ding Xiao, Hin Chu, Jian‐Piao Cai, Biao Zhou et al. · 2022 · Cell Discovery
  81. In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic
    Rafael Borges Rosa, Willyenne Marília Dantas, Jéssica Catarine Frutuoso do Nascimento, Murilo Vieira da Silva, Ronaldo N. de Oliveira, Lindomar Pena · 2021 · Viruses
  82. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
    J. Hazeldine, J. Lord · 2021 · Frontiers in Immunology
  83. Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
    Bin Zheng, Wenchang Peng, Mingming Guo, Mengqian Huang, Yuxuan Gu, Tao Wang, Guangjian Ni, Dong Ming · 2021 · Chemical Engineering Journal
  84. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
    Ashutosh Kumar Singh, Rahul Soloman Singh, Phulen Sarma, Gitika Batra, Rupa Joshi, Hardeep Kaur, Amit Raj Sharma, Ajay Prakash, Bikash Medhi · 2020 · Virologica Sinica
  85. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
    Praveen Mathews Varghese, Anthony George Tsolaki, Hadida Yasmin, Abhishek Shastri, Janez Ferluga, Manu Vatish, Taruna Madan, Uday Kishore · 2020 · Immunobiology
  86. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA
    Mythili Dileepan, Da Di, Qinfeng Huang, Shamim Ahmed, Daniel A. Heinrich, Hinh Ly, Yuying Liang · 2021 · Virulence
  87. SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells
    N. Huot, C. Planchais, Pierre Rosenbaum, V. Contreras, B. Jacquelin, Caroline Petitdemange, Marie Lazzerini, Emma Beaumont, Aurelio Orta-Resendiz, F. Rey et al. · 2023 · Nature Immunology
  88. Animal models for SARS‐CoV‐2 research: A comprehensive literature review
    Kabita Pandey, Arpan Acharya, Mahesh Mohan, Caroline L. Ng, St Patrick Reid, Siddappa N. Byrareddy · 2020 · Transboundary and Emerging Diseases
  89. Development and deployment of COVID-19 vaccines for those most vulnerable
    Wayne Chester Koff, Theodore Schenkelberg, Tere M. Williams, Ralph Steven Baric, Adrian B. McDermott, Cheryl Cameron, Mark J. Cameron, Matthew B. Frieman, Gabriele Neumann, Yoshihiro Kawaoka et al. · 2021 · Science Translational Medicine
  90. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
    Emma S. Winkler, Rita E. Chen, Fahmida Alam, Soner Yildiz, James Brett Case, Melissa B. Uccellini, Michael J. Holtzman, Adolfo García‐Sastre, Michael Schotsaert, Michael Diamond · 2021 · Journal of Virology
  91. COVID-19 Vaccines: Adenoviral Vectors
    Catherine Jacob-Dolan, Dan H. Barouch · 2021 · Annual Review of Medicine
  92. Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster
    Lun-Zhi Yuan, Hua-Chen Zhu, Ming Zhou, Jian Ma, Rirong Chen, Yao Chen, Liqiang Chen, Kun Wu, M. Cai, Junping Hong et al. · 2021 · Signal Transduction and Targeted Therapy
  93. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome—with a preliminary reference to SARS-CoV-2 pneumonia
    Walter Gottlieb Land · 2021 · Genes and Immunity
  94. Advances and gaps in SARS-CoV-2 infection models
    César Muñoz‐Fontela, Lina Widerspick, Randy A. Albrecht, Martin Beer, Miles W. Carroll, Emmie de Wit, Michael Diamond, William E. Dowling, Simon G. P. Funnell, Adolfo García‐Sastre et al. · 2022 · PLoS Pathogens
  95. An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2
    Katherine Camille Barnett, Yuying Xie, Takanori Asakura, Dingka Song, Kaixin Liang, Sharon Taft-Benz, Haitao Guo, Shuangshuang Yang, Kenichi Okuda, Rodney C. Gilmore et al. · 2022 · Cell Host & Microbe
  96. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression
    Keisuke Nakagawa, Shinji Makino · 2021 · Cells
  97. Are Animals a Neglected Transmission Route of SARS-CoV-2?
    Marta Hernández, David Abad, José María Eirós Bouza, David Rodrı́guez-Làzaro · 2020 · Pathogens
  98. Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2–Infected Hamsters: What Matters?
    Achim Dieter Gruber, Nikolaus Osterrieder, Luca D. Bertzbach, Daria Vladimirova, Selina Greuel, Jana Ihlow, David A. Horst, Jakob Trimpert, Kristina Dietert · 2020 · American Journal of Respiratory Cell and Molecular Biology
  99. The gut microbiome and antibiotic resistome of chronic diarrhea rhesus macaques (Macaca mulatta) and its similarity to the human gut microbiome
    Shengzhi Yang, Yu Liu, Nan Yang, Yue Lan, Weiqi Lan, Jinyi Feng, Bisong Yue, Miao He, Liang Zhang, Anyun Zhang et al. · 2022 · Microbiome
  100. Overcoming Barriers
    Dakota Gustafson, Sneha Raju, Ruilin Wu, Crizza Ching, Shawn Veitch, Kumaragurubaran Rathnakumar, Émilie Boudreau, Kathryn L. Howe, Jason E. Fish · 2020 · Arteriosclerosis Thrombosis and Vascular Biology